Boundless Bio Statistics

Total Valuation

Boundless Bio has a market cap or net worth of $82.56 million. The enterprise value is -$22.24 million.

Market Cap	82.56M
Enterprise Value	-22.24M

Important Dates

The next estimated earnings date is Monday, August 5, 2024, before market open.

Earnings Date	Aug 5, 2024
Ex-Dividend Date	n/a

Share Statistics

Boundless Bio has 22.25 million shares outstanding.

Shares Outstanding	22.25M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	10.80%
Owned by Institutions (%)	39.78%
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 10.54

Current Ratio	10.54
Quick Ratio	n/a
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Capital (ROIC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	-$738,125
Employee Count	72
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	6.65
200-Day Moving Average	n/a
Relative Strength Index (RSI)	32.71
Average Volume (20 Days)	109,254

Short Selling Information

The latest short interest is 733,794, so 3.30% of the outstanding shares have been sold short.

Short Interest	733,794
Short Previous Month	621,257
Short % of Shares Out	3.30%
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	n/a
Pretax Income	n/a
Net Income	-53.15M
EBITDA	n/a
EBIT	n/a
Earnings Per Share (EPS)	-$2.39

Full Income Statement

Balance Sheet

The company has $105.44 million in cash and $1.52 million in debt, giving a net cash position of $103.92 million or $4.67 per share.

Cash & Cash Equivalents	105.44M
Total Debt	1.52M
Net Cash	103.92M
Net Cash Per Share	$4.67
Equity (Book Value)	-141.18M
Book Value Per Share	-6.34
Working Capital	101.52M

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Boundless Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-65.07%
FCF Yield	n/a

Analyst Forecast

The average price target for Boundless Bio is $23.00, which is 519.95% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$23.00
Price Target Difference	519.95%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a